MétaCan
Menu
Back to cohort
Record W4401261376 · doi:10.1177/17588359241266179

Pan-Canadian consensus recommendations for GIST management in high- and low-throughput centres across Canada

2024· review· en· W4401261376 on OpenAlexaffabout
J. Robert Beecroft, Savtaj S. Brar, Xiaolan Feng, Trevor D. Hamilton, Cheng Han-Lee, Jan‐Willem Henning, P. David Josephy, Korosh Khalili, Yoo‐Joung Ko, Christopher Lemieux, David Liu, Danielle Macdonald, Jonathan Noujaim, Aaron Pollett, Abdulazeez Salawu, Ramy Saleh, Alannah Smrke, Blair E. Warren, Kevin Zbuk, Albiruni Abdul Razak

Bibliographic record

VenueTherapeutic Advances in Medical Oncology · 2024
Typereview
Languageen
FieldMedicine
TopicGastrointestinal Tumor Research and Treatment
Canadian institutionsMcMaster UniversityUniversité de MontréalHôpital Maisonneuve-RosemontMcGill University Health CentreUniversity of OttawaUniversité LavalCentre hospitalier universitaire de QuébecSt. Michael's HospitalSunnybrook Health Science CentrePrincess Margaret Cancer CentreMount Sinai HospitalVancouver General HospitalUniversity of CalgaryUniversity of AlbertaOttawa HospitalUniversity Health NetworkUniversity of TorontoUniversity of British ColumbiaBaker Hughes (Canada)
Fundersnot available
KeywordsGiSTMedicineImatinib mesylateFamily medicineImatinibPathologyInternal medicineStromal cell

Abstract

fetched live from OpenAlex

Gastrointestinal stromal tumours (GISTs) are mesenchymal tumours that originate from the interstitial cells of Cajal. GISTs are mainly driven by gain-of-function mutations in receptor tyrosine kinase or platelet-derived growth factor receptor alpha. Surgical resection is the only curative treatment for localized tumours and all currently approved medical GIST treatments are based on orally available tyrosine kinase inhibitors. Recent discoveries in the molecular and clinical features of GISTs have greatly impacted GIST management. Due to the provincially rather than nationally administered Canadian healthcare system, there have been inconsistencies in the treatment of GISTs across the country. Therefore, guidance on the latest knowledge, clinical management and treatment of GIST is needed to standardize the approach to GIST management nationwide. To establish pan-Canadian guidance, provide up-to-date data and harmonize the clinical practice of GIST management in high- and low-throughput centres across Canada; a panel of 20 physicians with extensive clinical experience in GIST management reviewed relevant literature. This included radiologists, pathologists, interventional radiologists, surgeons and medical oncologists across Canada. The structured literature focused on seven key domains: molecular profiling, radiological techniques/reporting, targeted localized therapy, intricacies of systemic treatments, emerging tests, multidisciplinary care and patient advocacy. This literature review, along with clinical expertise and opinion, was used to develop this concise and clinically relevant consensus paper to harmonize the knowledge and clinical practice on GIST management across Canada. The content presented here will help guide healthcare providers, especially in Canada, in terms of approaching and managing GIST.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.029
metaresearch head score (Gemma)0.080
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Review · Consensus signal: none
Teacher disagreement score0.868
Threshold uncertainty score0.956

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0290.080
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0020.003
Bibliometrics0.0100.011
Science and technology studies0.0090.004
Scholarly communication0.0080.004
Open science0.0100.006
Research integrity0.0060.006
Insufficient payload (model declined to judge)0.0120.003

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.062
GPT teacher head0.465
Teacher spread0.403 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2024
Admission routes2
Has abstractyes

Explore more

Same venueTherapeutic Advances in Medical OncologySame topicGastrointestinal Tumor Research and TreatmentFrench-language works237,207